| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4471870
Max Phase: Preclinical
Molecular Formula: C19H17N5O4
Molecular Weight: 379.38
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Cc1noc(C)c1Cn1cc(N2C(=O)C(=O)N(Cc3ccccc3)C2=O)cn1
Standard InChI: InChI=1S/C19H17N5O4/c1-12-16(13(2)28-21-12)11-22-10-15(8-20-22)24-18(26)17(25)23(19(24)27)9-14-6-4-3-5-7-14/h3-8,10H,9,11H2,1-2H3
Standard InChI Key: AHTLZRURDSTFOP-UHFFFAOYSA-N
Associated Targets(Human)
Taste receptor type 2 member 8 387 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 379.38 | Molecular Weight (Monoisotopic): 379.1281 | AlogP: 2.03 | #Rotatable Bonds: 5 |
| Polar Surface Area: 101.54 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 1.67 | CX LogP: 1.47 | CX LogD: 1.47 |
| Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.50 | Np Likeness Score: -2.00 |
References
| 1. Fotsing JR, Darmohusodo V, Patron AP, Ching BW, Brady T, Arellano M, Chen Q, Davis TJ, Liu H, Servant G, Zhang L, Williams M, Saganich M, Ditschun T, Tachdjian C, Karanewsky DS.. (2020) Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists., 63 (9): [PMID:32330040] [10.1021/acs.jmedchem.0c00388] |
Source
Source(1):